{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-25-091891","form_type":"8-K","ticker":"HCWB","cik":"0001828673","company_name":"HCW Biologics Inc.","filed_at":"2025-07-01T23:59:59+00:00","discovered_at":"2026-05-14T18:02:45.183166+00:00","generated_at":"2026-05-18T10:25:59.953977+00:00","sec_items":["8.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"confidence":"high","headline":"Armistice exercises remaining 54,000 pre-funded warrants; all warrants now fully exercised","bullets":["On June 18, 2025, Armistice Capital Master Fund exercised Pre-Funded Warrants for 54,000 shares of HCW Biologics common stock.","With this exercise, all 513,140 Pre-Funded Warrants originally granted are fully exercised and none remain outstanding.","Exercise price was $0.0001 per share, with negligible cash proceeds to the Company."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-25-091891","json":"https://secwatch.observer/filing/0000950170-25-091891.json","markdown":"https://secwatch.observer/filing/0000950170-25-091891.md","text":"https://secwatch.observer/filing/0000950170-25-091891.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1828673/000095017025091891/0000950170-25-091891-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1828673/000095017025091891/hcwb-20250618.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-18T10:25:59.953977+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}